2 news items
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
AUPH
2 May 24
energy and emissions, addressing barriers to care among LN patients, (Diversity, Equity and Inclusion) DE&I practices, employee engagement
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
AUPH
1 May 24
, Chief Executive Officer of Aurinia. "We are actively engaged in ongoing clinical research and educational initiatives supporting both patients
- Prev
- 1
- Next